PERPHENAZINE
Cocaine Dependence
Paul SaengerSmall moleculePhase 2Dormant
CCC
53/ 100
Provisional rating · Methodology v0.2
Rating breakdown
- Clinical Evidence
- 38/ 100
- Competitive Position
- 95/ 100
Competitive context
0 Active assets in the Cocaine Dependence cohort.
| Asset / Sponsor | Phase | Rating |
|---|---|---|
LAMOTRIGINE University of Texas Southwestern Medical Center | Phase 4 | BB |
Seroquel® University of Texas Southwestern Medical Center | Phase 4 | BB |
Citicoline University of Texas Southwestern Medical Center | Phase 4 | B |
LITHIUM, ELEMENTAL University of Miami | Phase 1/2 | CCC |
Valproic Acid University of Miami | Phase 1/2 | CCC |
Risperdal University of Texas Southwestern Medical Center | N/A | D |
Same molecule, other indications
PERPHENAZINE is also rated in:
Are you the sponsor?
Submit your data room for a Verified Rating. The public-data rating remains visible alongside.
Contact →